INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 100 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 2.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $153,000 | +142.9% | 15,205 | +204.4% | 0.00% | – |
| Q2 2017 | $63,000 | +37.0% | 4,995 | +13.0% | 0.00% | – |
| Q1 2017 | $46,000 | +17.9% | 4,419 | +4.7% | 0.00% | – |
| Q4 2016 | $39,000 | +160.0% | 4,219 | +222.6% | 0.00% | – |
| Q3 2016 | $15,000 | -25.0% | 1,308 | -13.3% | 0.00% | – |
| Q2 2016 | $20,000 | -35.5% | 1,508 | -21.0% | 0.00% | – |
| Q1 2016 | $31,000 | -3.1% | 1,908 | +68.6% | 0.00% | – |
| Q4 2015 | $32,000 | -13.5% | 1,132 | -13.5% | 0.00% | – |
| Q3 2015 | $37,000 | -2.6% | 1,308 | +100.0% | 0.00% | – |
| Q1 2015 | $38,000 | +123.5% | 654 | +62.7% | 0.00% | – |
| Q4 2014 | $17,000 | -37.0% | 402 | -42.7% | 0.00% | – |
| Q3 2014 | $27,000 | +1250.0% | 702 | +1250.0% | 0.00% | – |
| Q2 2014 | $2,000 | 0.0% | 52 | 0.0% | 0.00% | – |
| Q1 2014 | $2,000 | -33.3% | 52 | -22.4% | 0.00% | – |
| Q4 2013 | $3,000 | +50.0% | 67 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | – | 67 | +2133.3% | 0.00% | – |
| Q2 2013 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
| ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
| Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
| Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
| TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
| Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
| GAM Holding AG | 83,940 | $808,000 | 0.02% |
| SFMG, LLC | 11,994 | $115,000 | 0.02% |
| SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |